Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate combination chemotherapy for patients with extensive stage small
cell lung cancer combined with the potentially useful growth inhibiting effects of Gleevec.